Hematologic diseases, especially hematologic malignancies, are characterized by unique gene expression profiles, such as the BCR-ABL1 (breakpoint cluster region-Abelson 1) fusion gene in chronic myeloid leukemia (CML) and different gene expressions in thalassemia. This evidence concerns the gene ABL1 and hematologic disorder.